REVVITY, INC.

RVTY · XNYS

CIK 31791fmd_1WYWJ9ZCFZ6DEZAZ38SVJEW2AQManufacturing · Laboratory Analytical InstrumentsTemplate: Standard

Coverage: Dec 31, 2007 to Oct 04, 2026, 71 periods

Income Statement · Annual · Millions · USD
Line item	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Total revenues	2,116	2,257	2,778	2,884	2,663	3,828	3,312	2,751	2,755	2,856
Cost of revenue	665	709	1,437	–	–	–	–	–	–	–
Gross profit	1,013	1,074	1,341	1,396	2,110	2,434	1,990	–	–	–
Research and development	124	139	194	189	146	200	222	217	197	216
Selling, general and administrative	590	626	812	815	716	975	1,026	1,023	994	992
Operating income	295	296	324	362	867	1,258	743	301	347	357
Interest expense	42	44	67	64	50	–	104	99	96	92
Interest and investment income	1	3	1	1	1	2	4	72	73	31
Other non-operating income (expense)	(51)	1	(66)	(125)	(67)	(55)	(91)	(118)	(31)	(88)
Income before taxes	244	297	258	237	800	1,204	652	183	316	268
Income tax expense	28	140	20	9	170	314	139	3	33	28
Net income from continuing operations	216	157	237	228	631	889	513	180	283	240
Net income	234	293	238	228	728	943	569	693	270	241